We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Trends in Mammography Show Improved Cancer Detection Rates

By MedImaging International staff writers
Posted on 28 Feb 2017
A major new study has shown that the move from film to digital mammography has improved the rates of cancer detection by nearly 10%, and the rate of biopsies by nearly 3% rise.

The shift from film to digital mammography also increased the abnormal interpretation rate, and this might lead to more biopsies for benign tumors.

The US Breast Cancer Surveillance Consortium (BCSC) researchers from the University of Vermont Cancer Center published the results of their study online in the February 2017 issue of the journal Radiology. The results showed that cancer detection rates increased to 34.7 per 1,000, from 25.3 per 1,000 in 2005, while the recall rate to perform biopsies increased to 12.6%, from 8.0% in 2005. The researchers also discovered that the Positive Predictive Value (PPV) fell by 4% in the same.

Brian L. Sprague, PhD, lead author of the study, said, “Our goals in this study were to produce benchmarks that individual radiologists and breast imaging facilities can use to compare with their own practices and to convey trends in how the metrics have changed over the past 10 to 15 years. While the improvements in cancer detection rates are encouraging, the increased abnormal interpretation rate is somewhat troubling in that we’re trying to keep this rate down. The results of the study highlight specific areas where quality improvement initiatives should focus. Overall, there is a lot of good performance out there, but there are definitely areas for improvement in positive predictive value and abnormal interpretation rate."

Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Digital Radiographic System
OMNERA 300M
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
X-ray Diagnostic System
FDX Visionary-A

Channels

Nuclear Medicine

view channel
Image: The new tracer, 64Cu-NOTA-EV-F(ab′)2​, targets nectin-4, a protein strongly linked to tumor growth in both TNBC and UBC cancer types. (Wenpeng Huang et al., DOI: 10.2967/jnumed.125.270132)

PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers

Triple-negative breast cancer (TNBC) and urothelial bladder carcinoma (UBC) are aggressive cancers often diagnosed at advanced stages, leaving limited time for effective treatment decisions.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.